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ABSTRACT
Background    Vitamin E (VE, α-tocopherol) is a 
fat-soluble vitamin and is well known as an antioxi-
dant. A deficiency in VE induces oxidative stress in the 
brain and causes motor and memory dysfunction. The 
consumption of a VE-rich diet has been given much at-
tention in recent years, in regards to anti-aging and the 
prevention of age-related neuronal disorders.
Methods    A VE-deficient mouse model was prepared 
by feeding the animals a diet lacking VE.  In addition, 
to evaluate the effect of VE-containing rice bran (RB) 
on VE deficiency, a diet including RB was also provid-
ed.  VE levels in the brain tissue, as well as in the RB, 
were measured using an HPLC system. Behavioral tests, 
including rotarod, wheel running activity, Y-maze, and 
elevated plus maze were performed. To clarify the effect 
of VE deficiency and RB, we investigated the induction 
of heme oxygenase-1 (HO-1).  Histological studies were 
performed using HE staining and immunohistochemical 
studies were performed using antibodies against glial 
fibrillary acidic protein (GFAP) and ionized calcium 
binding adaptor molecule 1 (Iba1). 
Results    VE in the mouse brain under a VE-deficient 
diet was decreased, and recovered α-tocopherol levels 
were observed in the brain of mice fed an RB diet. Mo-
tor behavioral scores were decreased in VE-deficient 
conditions, while the supplementation of RB improved 
motor function. HO-1, a marker of oxidative stress, was 
upregulated in the mouse brain under VE deficiency, 
however, RB supplementation inhibited the increase of 
HO-1. Histological analyses showed neuronal degener-
ation of Purkinje cells and decreased GFAP-immunore-
activity of Bergmann glia in the cerebellum. In addition, 
activated astrocytes and microglia were observed in 
mice fed the VE-deficient diet.  Mice fed the RB diet 
showed improvement in these histological abnormalities. 
Conclusion    A VE-deficient diet induced motor dys-
function in mice due to the degeneration of Purkinje 
cells in the cerebellum. Oral supplementation of RB 
increases VE in the brain and improved the motor dys-
function caused by VE deficiency. Thus, RB or unpol-
ished rice may be a promising VE supplement.
Key words    antioxidant; Bergmann glia; oxidative 
stress; rice bran; vitamin E 
Vitamin E (VE) is a fat-soluble vitamin and is well 
known as a cell membrane antioxidant that protects cells 
and organs against oxidative stress. α-Tocopherol (αTOC) 
is the most studied form of VE, however, there are 8 
identified vitamin E derivatives: α-, β-, γ- and δ-tocoph-
erol (αTOC, βTOC, γTOC and δTOC, respectively) and 
α-, β-, γ- and δ-tocotrienol (αT3, βT3, γT3 and δT3, 
respectively).1, 2 These classes, TOCs and T3s, can be 
differentiated by an unsaturated side chain with three 
double bonds in the farnesyl isoprenoid tail of TOCs 
and an isoprenoid tail with 3 double bonds in T3s.1, 2 
Furthermore, differences between α-, β-, γ- and δ- are 
characterized by the number and location of methyl 
groups on the chromanol ring. Numerous reports have 
suggested that all types of VE scavenge reactive oxygen 
species and protect cells and organs against oxidative 
stress.3–5 Furthermore, it has been reported that VE de-
rivatives also stimulate intracellular signal transduction 
and protect cells in antioxidant independent manner.2, 6 
 Epidemiological and clinical studies suggest that VE 
is important for the prevention of oxidative stress-related 
neurodegenerative disorders such as Parkinson’s dis-
ease,7–9 Alzheimer’s disease10 and amyotrophic lateral 
sclerosis.11 Moreover, it has been reported that αTOC 
deficiency induced through the lack of αTOC transfer 
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protein (αTTP) induces cerebellar ataxia in humans and 
mice.12-14 These findings suggest that VE is essential for 
the maintenance of brain integrity.
 αTTP is an abundant cytosolic liver protein with 
high binding affinity to αTOC, but not to other VE 
derivatives. αTTP can transport αTOC between sepa-
rate membranes.15 αTTP is present in the brain and is 
concentrated in Purkinje cell layers of the cerebellum.16 
Moreover, a detail examination of the rat brain revealed 
that αTTP is expressed in Bergmann glia located be-
tween Purkinje cells, which are important in maintain-
ing the functional stability of cerebellar Purkinje cells.16 
These facts suggest that the cerebellum is more vul-
nerable to αTOC deficiency compared with other brain 
regions.   
 Rice brain (RB), a byproduct of the rice milling 
process, is known to be a rich source of antioxidants 
including VE. Although the concentrations of TOCs and 
T3s in RB vary according to the rice species and milling 
techniques, RBs have abundant TOCs and T3s.17, 18 It 
has been reported that dietary RB is useful for intestinal 
regulation, decreasing low density lipoprotein, and low-
ering blood pressure.19–21 In the present study, we inves-
tigated the effects of dietary RB on neuronal abnormali-
ties such as cerebellar ataxia induced by VE deficiency. 
MATERIALS AND METHODS
Animals
C57BL/6 mice were obtained from CLEA Japan (Tokyo, 
Japan). The mice were housed under standardized con-
ditions of light (06:00–18:00), temperature (25 °C), and 
humidity (approximately 50%), and were allowed free 
access to food and water. The mice used in this study 
were treated in accordance with the Guideline for Ani-
mal Experimentation of Tottori University (No. 14-Y-03). 
 VE-deficient feed (VEdef) (Funabashi Farm, Chiba, 
Japan), normal feed and RB were prepared. In order to 
investigate an effect of RB, mice were fed 5 types of 
feed. The diets were as follows: i) VEdef alone (n = 4); 
ii) a mixture of VEdef and RB at a concentration 2% 
RB (n = 4); iii) a mixture of VEdef and RB at a concen-
tration 5% RB (n = 4); iv) normal diet alone (n = 6) and 
v) a mixture of normal diet and RB at a concentration 
5% RB (n = 6). Hereafter, these diets are referred to as 
VEdef, 2%RB, 5%RB, NR and NR5%RB, respectively.  
 Mice were supplied with the above-mentioned diets 
from 8 to 20 weeks of age. Behavior analyses were per-
formed at 0, 0.5, 1, 2, 3 months, and, after 3 months, the 
brain was sampled.
Behavioral test
Rotarod test
The motor coordination of mice was investigated using 
an accelerating rotarod apparatus (MK-630B treadmill; 
Muromachi, Tokyo, Japan). The mice were placed on 
the rod for four successive trials. The two highest scores 
of the four trials were used to calculate an average score, 
which indicates the latency to fall. During each trial, the 
rotating rod accelerates gradually from 0 to 40 rpm over 
a period of 5 min, and, thereafter, is maintained at the 
40 rpm speed.
Wheel running activity (WRA)
WRA was investigated using the MK-750PC (Muroma-
chi). Locomotor and running activity was converted to 
revolutions per day. The mice were allowed free exer-
cise, rest, food and water for 24 hours.
Y-maze
The Y-maze apparatus was composed of three arms with 
walls of 10 cm wide, 13 cm high, and 35 cm long, allow-
ing the mice to see distal spatial features. The insides of 
the arms were identical to each other, and provided no 
interior cues.
 Continuous spontaneous alternation testing was 
performed by placing the mice in the Y-maze for 8 min 
with all three arms. The number and sequence of arms 
entered were recorded manually. 
 One alternation was counted when mice visited 
three different arms consecutively. Immediate reentries 
were discounted. The percentage of alternation was 
indicated as spatial working memory. The spontaneous 
alternative rate (%) was calculated as the number of al-
ternations/(the number of total arm entries –2) × 100.
Elevated plus maze test
The elevated plus maze consisted of two arms without 
walls (6 cm wide × 30 cm length) and two enclosed by 
walls (6 cm wide × 30 cm length × 20 cm height), with a 
center area of 6 × 6 cm. This apparatus was elevated to 
height of 50 cm from the ground. The mice were placed 
at the center area, and allowed to explore the maze for 
5 min. The time spent in the open arms and the number 
of open arm entries were counted and estimated as pa-
rameter of anti-anxiolytic behavior. All measuring were 
recorded manually.
Quantification of vitamin E
Mice were decapitated under deep anesthesia (pentobar-
bital, 50 mg/kg, i.p.) and brain tissues were collected. A 
portion of the brain tissue (approximately 200 mg) was 
crushed by a polytron homogenizer in 1.5 mL phosphate 
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buffered saline (PBS). To prevent oxidation of the sam-
ples, this procedure was performed on ice and under a 
nitrogen gas stream.
 The homogenates were used for the measurement of 
VE and quantification of protein concentration. Mixture 
of the brain homogenate and 2.0 mL ethanol was trans-
ferred to a glass tube with a screw cap, then, after added 
5.0 mL n-hexane, it was shaken vigorously for 20 min. 
 The tube was centrifuged at 750 × g for 5 min, and 
the hexane layer was collected in another glass tube. Af-
ter 5.0 mL of n-hexane was added again, re-extraction 
(shaking, centrifuging and collection of hexane layer) 
was performed. The collected hexane layer was evapo-
rated under nitrogen gas stream. The fat-soluble extract 
that remained was dissolved in 0.5 mL ethanol, passed 
through a 0.22 μm filter to remove impurities, and col-
lected in a storage glass tube. 
 Similarly, 1.0 g of each feed (5 types of feed and the 
RB used for the experiment) was treated with the same 
procedures as extraction of the brain.
 αTOC, γTOC, δTOC, αT3, γT3 and δT3 in the 
fat-soluble fraction extracted from brain or feed were 
quantified by a high performance liquid chromatography 
(HPLC) system. VE levels in the brain were measured 
using an HPLC system equipped with an absorbance de-
tector (295 nm) and a phenylhexyl column (COSMOSIL 
πNAP; Nacalai Tesque, Kyoto, Japan). Methanol 90%/
H2O 10% delivered at a flow rate of 1 mL/min was used 
as eluent. αT3, γT3 and δT3 purified from palm for stan-
dards in HPLC were donated by Eisai Food & Chemical 
(Tokyo, Japan). αTOC, γTOC and δTOC were obtained 
from Sigma (St. Louis, MO).
Immunoblot
Brain tissues were lysed in SDS sample buffer (50 
mM Tris–HCl, pH 6.8, 2% SDS, 10% glycerol, 1 mM 
phenylmethylsulfonyl fluoride, and 2 mM ethylenedi-
aminetetraacetic acid). Aliquots (20 μg) were separated 
on the basis of molecular size on 10% polyacrylamide 
gels, transferred onto polyvinylidene difluoride mem-
branes (Hybond-P; GE Healthcare, Buckinghamshire, 
UK), and hybridized with HO-1 or β-actin antibody in 
PBS with 0.1%Tween 20 at room temperature for 1 h. 
Primary antibodies against hemeoxigenase-1 (HO-1) 
and β-actin were obtained from Santa Cruz Biotechnol-
ogy (Dallas, TX) and Cell Signaling Technology (Dan-
vers, MA), respectively. The immunoreactive signal was 
detected using horseradish peroxidase-linked anti-rabbit 
or mouse IgG and ECL detection reagents (GE Health-
care). The protein content of each sample was measured 
using the bicinchoninic acid (BCA) protein assay system 
(Thermo Fisher Scientific Inc, Rockford, IL). The densi-
ty of immunoblot signal (expressed as the ratio of HO-1/
β-actin) was semi-quantified using Image J software. 
Semi-quantitative data were assessed by ANOVA using 
the Stat View software, and the criterion for statistical 
significance was P < 0.05.  
Histological study 
Immunohistochemistry was performed on paraffin-em-
bedded sections of mouse brain tissues. A portion of 
brain tissue was fixed by immersion in 4% paraformal-
dehyde (Wako, Osaka, Japan), and embedded in paraffin. 
Paraffin sections (4 μm) were deparaffinized by placing 
slides into three changes of xylene, followed by rehydra-
tion in a graded ethanol series. Sections were treated with 
methanol with 3% H2O2 at room temperature for 30 min 
to reduce endogenous peroxidase activity.
 For glial fibrillary acidic protein (GFAP) and ion-
ized calcium binding adaptor molecule 1 (Iba1) staining, 
the sections were rinsed in water and subjected to anti-
gen retrieval in 10 mM citrate (pH 6.0) at 121 °C for 10 
min in an autoclave. GFAP was detected by incubating 
the sections in GFAP antibody at a 1:1000 dilution in 
PBS at 4 °C overnight. Iba1 antibody was used at a 1:1000 
dilution. The labeled antigens were visualized using the 
Histo Fine kit (Nichirei, Tokyo, Japan) for GFAP and 
Iba1, followed by 3,3-diamiobenzidine (DAB) reaction. 
Finally, the sections were counterstained with hematox-
ylin and observed by microscopy (BZ-9000; Keyence, 
Osaka, Japan). Primary antibody comprised goat an-
tibody to GFAP and Iba1 were obtained from Abcam 
(Cambridge, UK).
RESULTS
Vitamin E quantification of the brain and feeds
In order to investigate the effect of VE in the RB on VE 
deficiency in the brain, quantification of VE homologs 
in the brain tissue and feeds used in this study were per-
formed by HPLC.
 First, all VE homologs in the RB used in this study 
were measured, except for βTOC and βT3 (Table 1). Al-
though αTOC, αT3, γTOC, γT3 and δTOC were detect-
ed, detectable levels of δT3 were not observed. The RB 
used in this experiment included predominately αTOC, 
γTOC and δTOC. The concentrations of T3s were lower 
than those of TOCs. As a next step, we measured the 
concentration of αTOC in each feed used in this exper-
iment. The concentration of αTOC in VEdef, 2%RB, 
5%RB, NR and NR5%RB were 0.66 ± 0.83 nmol/g, 
15.55 ± 25.14 nmol/g, 31.51 ± 59.05 nmol/g, 477.93 ± 
82.74 nmol/g and 546.16 ± 33.24 nmol/g, respectively. 
 Furthermore, we measured the concentration of VE 
homologs in the brain tissue at 3 months after the start 
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Table 1. Concentration of tocopherols and tocotrienols in rice bran (nmol/g)
αTOC γTOC δTOC αT3 γT3 δT3
60.86 ± 6.06 182.97 ± 16.36 125.05 ± 19.86 28.02 ± 2.02 3.94 ± 2.45 N.D.
αT3, α-tocotrienol; αTOC, α-tocopherol; δT3, δ-tocotrienol; δTOC, δ-tocopherol; γT3, γ-tocotrienol; γTOC, γ-tocopherol; N.D., not de-
tected.
of special feeds administration. As expected, the amount 
of αTOC in the VEdef mouse brain was notably lower, 
while αTOC levels in 5%RB mice were comparable 
to those in NR mice (Table 2). The concentrations of 
αTOC in the brains of each feed group is shown in Table 
2. Since αTOC levels in the brain from NR5%RB mice 
was similar to that from NR mice, we omitted NR5%RB 
mice by the later experiments. Other VE homologs, such 
as γTOC, δTOC, αT3, γT3 and δT3, were not detected 
because their concentrations in the brain were lower 
than that detectable by our HPLC system. 
Behavioral analyses
To evaluate the effects of oral supplementation of RB 
on the improvement of behavioral disorders caused by 
dietary loss of VE, we utilized the rotarod test, WRA, 
Y-maze test, and elevated plus maze test in all groups of 
mice.
 The rotarod test was performed in order to investi-
gate motor coordination or movement memory of mice 
(Fig. 1A). Although the rotarod score of normal mice 
is progressed with every test attempt, this progression 
was not observed in VEdef mice. VEdef mice displayed 
a significant decrease of duration time on the rotarod 
compared with NR mice at 3 months, while the 5%RB 
mice showed a significant increase of the rotarod score 
compared with that of VEdef mice.
 We measured the spontaneous activity levels of 
mice managed under the VE-deficient feed with or with-
out δT3 using an activity wheel for mice (Fig. 1B). Al-
though the mice under VE-deficient conditions showed 
a decrease in activity, the mice managed under VEdef 
Table 2. Vitamin E concentration in each feed
Feed αTOC (nmol/g)
NR 477.93 ± 82.74
NR5%RB 546.16 ± 33.24
VEdef 0.66 ± 0.83
2%RB 15.55 ± 25.14
5%RB 31.51 ± 59.05
2%RB, a mixture of vitamin E deficient feed and RB at a concen-
tration 2% rice bran; 5%RB, a mixture of vitamin E deficient feed 
and RB at a concentration 5% rice bran; αTOC, α-tocopherol; 
NR, normal diet alone; NR5%RB,  a mixture of normal diet and 
RB at a concentration 5% rice bran; VE, vitamin E; VEdef, vita-
min E-deficient feed. 
with 5% RB showed a recovery of spontaneous activity. 
 To investigate anxiety behavior or deficits in short-
term memory in these mice, the Y-maze and the elevat-
ed plus maze were performed at the same time as the 
locomotor analysis. At 3 months after the start of the 
experiment, we observed no difference between the VE-
def mice and the other groups in the non-motility tests. 
Briefly, spontaneous alternative scores in the Y-maze test 
were 51.8 ± 5.14%, 57.7 ± 7.83% and 59.5 ± 2.78% in the 
VEdef, 2%RB and 5%RB groups, respectively. More-
over, the average of the time spent on open arms were 
18.0 sec, 20.0 sec and 17.72 sec in the VEdef, 2%RB and 
5%RB groups, respectively. 
Measurement of oxidative stress marker
Because VE has anti-oxidative activity, chronic VEdef 
may induce oxidative stress. We investigated the expres-
sion of HO-1 in the brain by immunoblot analyses as an 
oxidative stress marker. 
 The expression of HO-1 in the brain increased 
significantly in VEdef mice compared with NR mice, 
whereas the expression significantly decreased in 5%RB 
mice compared with VEdef mice (Fig. 2).
 These results suggest that the influence of VEdef 
on the brain is reflected in increasing oxidative stress, 
which may be prevented by ingestion of (at least 5%) 
RB.
Histological analysis 
Histological analyses were performed by taking advan-
tage of the brain tissue sampled at the time of HPLC 
analysis. Degeneration of Purkinje cells was observed 
in the cerebellum of VEdef mice at 3 months after the 
start of the experiment (Fig. 3B). On the other hand, in 
the RB5% mice, degeneration of Purkinje cells was mild 
(Fig. 3C) compared with the VEdef mouse cerebellum. 
Furthermore, we investigated the effect of the VEdef 
and RB diets on Bergmann glia, which help maintain 
Purkinje cells (Figs. 3D–I). Although GFAP-positive 
Bergman glia were observed around Purkinje cells in 
NR mice (Figs. 3D and G), GFAP immunoreactivity 
of the Bergmann glia decreased in the VEdef mouse 
cerebellum (Figs. 3E and H).  On the other hand, GFAP 
immunoreactivity was recovered in the cerebellum from 
5%RB mice (Figs. 3F and I). 
 Next, we investigated the effect of VEdef and RB 
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Fig. 1. Behavioral changes due to administration of VE-defi cient 
diet or RB-containing diet.
5%RB mice displayed increased movement behavior in the ro-
tarod (A) and WRA tests (B) compared with the VEdef mice. 
Each group of mice NR (n = 6), VEdef (n = 4), 2%RB (n = 4) 
and 5%RB (n = 4) was subjected to the rotarod and WRA test. 
(A) Performance of each group of mice in the rotarod test. This 
score displays the mean of latency to fall. There is a signifi cant 
difference between the VEdef and 5%RB mice at 3 months. (B) 
WRA was measured each month after the experiment started. 
There is a signifi cant difference between VEdef and 5%RB mice 
at 3-months. *P < 0.05 vs. VEdef at same month (ANOVA). NR, 
normal diet alone; RB, rice bran; 2%RB, a mixture of vitamin E 
defi cient feed and RB at a concentration 2% rice bran; 5%RB, a 
mixture of vitamin E defi cient feed and RB at a concentration 5% 
rice bran; VE, vitamin E; VEdef, vitamin E-defi cient feed; WRA, 
wheel running activity.
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Fig. 2. The expression of heme oxygenase-1 in the mouse brain. 
(Above) Quantifi ed data of the relative expression of HO-1 in the 
brain normalized against β-actin expression. Homogenized whole 
brains were used for this analysis. A graph indicates relative val-
ues against NR (a reference value of 1.0). (Below) A representative 
example of an immunoblotting experiment. Upper panel shows 
HO-1 (32kDa) and lower panel shows β-actin (45kDa). HO-1 is 
upregulated in the brain of VEdef mouse, whereas that in 5%RB 
is signifi cantly decreased. *P < 0.05 vs. NR, **P < 0.05 vs. VEdef 
(ANOVA). n = 4–6 (mean ± S.E.). HO-1, heme oxygenase-1; NR, 
normal diet alone; VEdef, vitamin E-defi cient feed. 
supplement on neuronal loss in the hippoccampus. In 
our experimental conditions, a signifi cant loss of pyra-
midal neurons in the hippocampus was not observed 
(Figs. 4A–C). Furthermore, to confirm the activity of 
astrocytes and microglia in the hippocampus, we per-
formed immunostaining with anti-GFAP (Figs. 4D–F), 
as well as anti-Iba1 antibody (Figs. 4G–I). In the hippo-
campus of each group, although there was a consistent 
level of staining intensity of glial cells, the immunore-
activity in VEdef mice was more intense than that of 
the other feed group (Figs. 4E and H). The activation of 
astrocyte and microglia, as indicated by complicating 
spinous processes and swollen cell bodies was observed 
in the VEdef mouse hippocampus (Figs. 4E and H). In 
the hippocampus of the brain from 5%RB mice, the 
degree of activation of astrocytes and microglia was less 
than that observed in VEdef mice (Figs. 4F–I).
DISCUSSION
Traditionally, VE has been described as having anti-
oxidant activity.3–5 The αTOC-mediated free radical 
quenching reaction is extremely fast (~108/M/sec), and 
the water soluble antioxidant ascorbic acid (vitamin C) 
is thought to recycle the oxidized αTOC radical gener-
ated during a redox reaction back to reduced αTOC.5, 22 
Therefore, VE is a powerful antioxidant in vivo.
 VE derivatives are found in the cell membrane of 
various foods. However, T3s are found only in a few 
vegetable fats such as palm oil and RB oil.23, 24 RB is 
byproduct of the rice milling process and has abundant 
nutrients including both TOCs and T3s. Therefore, RB 
is a promising oral supplement to provide VE. 
 A mutation of the αTTP gene has been reported as au-
tosomal recessive familial VE defi ciency in human.25, 26 In 
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Fig. 3. Histological analyses of the cerebellum.
(A–C) HE staining of the cerebellum. Bar = 100 μm. (A) The cerebellum from NR mice. Arrows indicate Purkinje 
cells (PC). (B) VEdef mouse cerebellum shows neuronal degeneration of Purkinje cells (white arrow heads). (C) Ad-
dition of 5%RB inhibits the neuronal degeneration of Purkinje cells. Neurodegeneration (white arrow head) is reduced 
compared to that in VEdef mice. (D–I) Immunohistochemistry using anti-GFAP antibody. (D–F) Low magnifi cation. 
Bar = 200 μm. (G–I) High magnifi cation. Bar = 50 μm. GC: Granule cell layer. PC: Purkinje cells. BG: Bergmann 
glia. (D and G) GFAP positive Bergmann glia (black arrow heads) are observed around Purkinje cells. (E and H) 
GFAP immunoreactivity in Bergmann glia is reduced in the cerebellum of VEdef mice compared to NR or RB5% 
mice. (F and I) The GFAP immunoreactivity of Bergmann glia is recovered by 5%RB supplementation. GFAP, glial 
fi brillary acidic protein; HE, hematoxylin-eosin; NR, normal diet alone; RB, rice bran; 5%RB, a mixture of vitamin E 
defi cient feed and RB at a concentration 5% rice bran; VE, vitamin E; VEdef, vitamin E-defi cient feed.
this family, patients show phonotypes that include cere-
bellar ataxia similar to spinocerebellar ataxia, and high 
dose supplementation of VE early in the disease process 
may, to some extent, reverse ataxia and mental deteriora-
tion. Since αTTP is expressed in Bergmann glia, which 
help maintain cerebellar Purkinje cells,16 a loss of func-
tion of αTTP may cause cerebellar degeneration.  This 
suggests that the cerebellum may be vulnerable against 
VE defi ciency, even with the normal αTTP gene product 
activity. αTTP-deficient mice also show a phenotype 
similar to human αTTP defi ciency.12
 In this study, we investigated the effect of oral sup-
plementation with RB as a source of VE on motor and 
cognitive function in mice fed a VE-deficient diet. In 
our experimental conditions, VE deficiency induced 
decreased activity of motor function, but not cognitive 
function and anxiety. The rotarod score, an index of 
motor function including balance and exercise learn-
ing, showed a low latency in the VEdef group, and also 
showed recovered latency in the RB5% group (Fig. 1A). 
Furthermore, we observed Purkinje cell degeneration 
and reduced GFAP immunoreactivity of Bergmann glia 
in the cerebellum, suggesting that cerebellar dysfunction 
by VE defi ciency caused motor dysfunction and that RB 
supplement rescued this cerebellar dysfunction (Fig. 3). 
 The WRA test showed mildly lowered scores in 
VEdef mice and a recovery effect of RB against VE 
deficiency (Fig. 1B). In order to investigate the cause 
of this lowered activity, we examined the loss of do-
paminergic neurons in the substantia nigra, which has 
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Fig. 4. Histological analyses of the hippocampus.
(A–C) HE staining of CA1 area in the hippocampus. Significant cell loss of the pyramidal neurons was not observed 
even in VEdef mice. Bar = 100 μm. (D–F) Immunohistochemistry for astrocytes using anti-GFAP antibody. Bar 
= 100 μm. (D) GFAP positive astrocytes are observed in the hippocampus. (E) Numbers of reactive astrocyte with 
complicating spinous processes and swelling of the cell body are observed in VEdef mouse hippocampus. (F) Fewer 
reactive astrocytes are observed in the hippocampus of 5%RB mice than VEdef mice. (G–I) Immunohistochemistry 
for microglia using the anti-Iba1 antibody. Bar = 10 μm. (G) Iba1 immunoreactive microglia. (H) Iba1 immunoreac-
tive microglia shows a swollen cell body with complicated spinous processes. (I) Microglia with decreased spinous 
processes compared with that in the VEdef mouse hippocampus are observed in the 5%RB mouse brain. GFAP, glial 
fibrillary acidic protein; HE, hematoxylin-eosin; Iba1, ionized calcium biding adaptor molecule 1; 5%RB, a mixture of 
vitamin E deficient feed and RB at a concentration 5% rice bran.
been shown to decrease activity.27 In our experimental 
conditions, significant neuronal loss was not observed in 
the substantia nigra (data not shown). Therefore, we con-
cluded the reduced WRA score in VEdef mice is due to 
cerebellar dysfunction. 
 Since VE deficiency induces non-motor dysfunc-
tion and neuronal loss in the brain,28 we examined the 
effect of VE deficiency and oral supplementation of RB 
on cognitive function and anxiety. Although reactive 
astrocytes and activated microglia were observed in 
the hippocampus, a loss of pyramidal neurons was not 
observed in the VEdef mouse brain (Fig. 4). This result 
is consistent with the result of the cognitive and anxiety 
examination using the Y-maze system and the elevated 
plus maze test. Since our experimental procedures was 
designed for only 3 months, longer-term experiments 
using the VEdef diet may show similar results as those 
described by Fukui, et al.28  
 It has been reported that TOCs and T3s have cyto-
protective function due to not only antioxidative activity, 
but also antioxidant-independent activities including 
intracellular signal transduction.6, 27 However, judging 
from the induction and/or inhibition of HO-1, the protec-
tive effect of RB may due to an antioxidative function. 
Several antioxidative ingredients, as well as VE, may 
be included in RB. Therefore, the effect by other ingre-
dients should also be considered, and further study is 
needed.  
 The RB used in this study was rich in TOCs rather 
than in T3s (Table 1). Therefore, oral supplementation 
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of RB increased αTOC in the brain, decreased oxidative 
stress, and improved motor function and histological 
abnormalities induced by VE deficiency. These results 
suggest that RB is useful as a supplement food for VE. 
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